Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia

Completed · Phase 2

Conditions studied: Insomnia

In brief

The purpose of this study is to evaluate the change in measures of physiological arousal before and after behavioral treatment of insomnia.

Key facts

Study ID

NCT00303342

Run by

Brigham and Women's Hospital

People needed

60

Starts

2006-03-01

Expected to finish

2009-06-01

Last updated by the study team

2010-01-14

Who can join

Age: 21 and older, up to 59. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• primary insomnia for 6 months
• average total wake time >60 minutes and sleep efficiency <80%
• at least 1 daytime complaint due to insomnia
• adequate opportunity and circumstance for sleep

You may not qualify if…

• current psychiatric condition
• medical condition that interferes with sleep
• pregnancy
• rotating shift work, night work or transcontinental travel during study
• anticipated major life stressor over the course of the study
• use of hypnotic or psychoactive medications
• no idiopathic or sleep state misperception insomnia

Where it is running

• Sleep Disorders Program, Brigham and Women's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.